Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (7,777,101)	$ (3,846,194)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	27,077	16,194
Share-based compensation	785,506	283,030
Interest accrued on convertible affiliated note		743,695
Change in fair value of convertible affiliated note		(684,436)
Changes in operating assets and liabilities:
Prepaid expenses	(181,974)	(135,468)
Accounts payable	642,226	(306,813)
Accrued liabilities and other current liabilities	1,191,631	146,469
Other operating assets and liabilities	1,116,150	(425,150)
Net cash used in operating activities	(4,196,485)	(4,208,673)
Cash flows from investing activities:
Purchases of plant and equipment		(39,520)
Net cash used in investing activities		(39,520)
Cash flows from financing activities:
Proceeds from option exercises	689
Proceeds from issuance of convertible affiliated note		2,324,499
Net cash provided by financing activities	689	2,324,499
Effect of exchange rate changes on cash	(4,586)	42,812
Net decrease in cash and cash equivalents	(4,200,382)	(1,880,882)
Cash and cash equivalents, beginning of period	38,888,828	2,691,156
Cash and cash equivalents, end of period	34,688,446	$ 810,274
Supplemental cash flow information:
Cash paid for interest	1,550
Supplemental disclosures - non-cash activities:
Purchases of plant and equipment in accounts payable and accrued liabilities	$ 91,928